Autopsy report · NCT00068666
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
Cause of deathNo reason given
Life of this trial
- Registered 4 months before it started.
- Ran for about 6 years 2 months before it stopped.
- 41 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Alliance for Clinical Trials in Oncology
- Sponsor type
- University, hospital or other
- Conditions
- Melanoma (Skin); Metastatic Cancer
- Interventions
- temozolomide; radiation therapy
- Participants
- 41
- Sites
- 45
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.